title: Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.
authors.affiliation: Research Institute for Internal Medicine, Rikshospitalet, Oslo University Hospital, Norway. thor.ueland@medisin.uio.no
authors.forename: Thor
authors.initials: T
authors.lastname: Ueland
authors.forename: Anders P
authors.initials: AP
authors.lastname: Jørgensen
authors.forename: Kristin
authors.initials: K
authors.lastname: Godang
authors.forename: Kristian J
authors.initials: KJ
authors.lastname: Fougner
authors.forename: Pål
authors.initials: P
authors.lastname: Aukrust
authors.forename: Pia
authors.initials: P
authors.lastname: Burman
authors.forename: Jens
authors.initials: J
authors.lastname: Bollerslev
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000328:Adult; D001823:Body Composition / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D053590:Interleukin 1 Receptor Antagonist Protein / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010919:Placebos
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein; D010919:Placebos; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I